“Chimeric ScFv Monoclonal Antibody Composed of Tocilizumab-Light Chain, Heavy Chain, and Bacterial Flagellin for the Treatment of Autoimmune Disorder: Insilco Design and Cytotoxicity Study” (2022) Journal of Pharmaceutical Negative Results, pp. 644–659. Available at: https://pnrjournal.com/index.php/home/article/view/2794 (Accessed: 30 June 2026).